HEADER TRANSFERASE 24-DEC-19 6LLX TITLE DISCOVERY OF A DUAL INHIBITOR OF NQO1 AND GSTP1 FOR TREATING MALIGNANT TITLE 2 GLIOBLASTOMA COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE S-TRANSFERASE P; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GST CLASS-PI,GSTP1-1; COMPND 5 EC: 2.5.1.18; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSTP1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OXIDATIVE STRESS, NQO1, GSTP1, GBM, SMALL MOLECULAR INHIBITOR, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.YE,H.LI,K.C.LEI REVDAT 2 22-NOV-23 6LLX 1 REMARK REVDAT 1 25-NOV-20 6LLX 0 JRNL AUTH K.LEI,X.GU,A.G.ALVARADO,Y.DU,S.LUO,E.H.AHN,S.S.KANG,B.JI, JRNL AUTH 2 X.LIU,H.MAO,H.FU,H.I.KORNBLUM,L.JIN,H.LI,K.YE JRNL TITL DISCOVERY OF A DUAL INHIBITOR OF NQO1 AND GSTP1 FOR TREATING JRNL TITL 2 GLIOBLASTOMA. JRNL REF J HEMATOL ONCOL V. 13 141 2020 JRNL REFN ISSN 1756-8722 JRNL PMID 33087132 JRNL DOI 10.1186/S13045-020-00979-Y REMARK 2 REMARK 2 RESOLUTION. 1.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.11 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 70364 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.840 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.1100 - 3.8063 0.98 5095 152 0.1951 0.2194 REMARK 3 2 3.8063 - 3.0231 1.00 4960 146 0.2038 0.2012 REMARK 3 3 3.0231 - 2.6415 0.99 4897 150 0.2164 0.2427 REMARK 3 4 2.6415 - 2.4002 1.00 4914 143 0.2084 0.2400 REMARK 3 5 2.4002 - 2.2283 1.00 4907 145 0.2021 0.2114 REMARK 3 6 2.2283 - 2.0970 1.00 4865 131 0.2065 0.2179 REMARK 3 7 2.0970 - 1.9920 1.00 4856 144 0.2093 0.2460 REMARK 3 8 1.9920 - 1.9053 1.00 4912 139 0.2082 0.2468 REMARK 3 9 1.9053 - 1.8320 1.00 4812 145 0.1963 0.2150 REMARK 3 10 1.8320 - 1.7688 1.00 4864 149 0.1917 0.2377 REMARK 3 11 1.7688 - 1.7135 1.00 4867 124 0.1754 0.2178 REMARK 3 12 1.7135 - 1.6646 1.00 4810 151 0.1774 0.1824 REMARK 3 13 1.6646 - 1.6207 1.00 4833 147 0.1753 0.2304 REMARK 3 14 1.6207 - 1.5812 0.98 4772 134 0.1820 0.2269 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.130 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.600 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.38 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 11.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6LLX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-DEC-19. REMARK 100 THE DEPOSITION ID IS D_1300015035. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-NOV-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9789 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 70461 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.580 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.10500 REMARK 200 R SYM (I) : 0.09400 REMARK 200 FOR THE DATA SET : 32.6100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : 0.21300 REMARK 200 R SYM FOR SHELL (I) : 0.23800 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3GUS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES PH5.8 ,30% PEG6000 ,10MM DTT, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.82750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.66200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.08950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.66200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.82750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.08950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -5 REMARK 465 HIS A -4 REMARK 465 MET A -3 REMARK 465 ALA A -2 REMARK 465 SER A -1 REMARK 465 MET A 0 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 36 CG CD OE1 OE2 REMARK 480 LYS A 120 CD CE NZ REMARK 480 LYS A 127 CD CE NZ REMARK 480 LYS A 140 CD CE NZ REMARK 480 GLU B 36 CG CD OE1 OE2 REMARK 480 LYS B 120 CD CE NZ REMARK 480 LYS B 127 CD CE NZ REMARK 480 LYS B 140 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 447 O HOH A 632 1.98 REMARK 500 O HOH A 452 O HOH B 427 2.06 REMARK 500 O HOH A 434 O HOH B 427 2.07 REMARK 500 O HOH A 443 O HOH A 649 2.16 REMARK 500 O HOH A 475 O HOH A 600 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 502 O HOH B 502 4544 1.98 REMARK 500 O HOH A 600 O HOH B 493 2455 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 64 112.49 84.49 REMARK 500 TYR A 79 35.23 -145.73 REMARK 500 ASN A 110 40.00 -160.88 REMARK 500 THR A 141 -100.85 -119.45 REMARK 500 GLN B 64 110.65 88.11 REMARK 500 TYR B 79 34.49 -143.41 REMARK 500 ASN B 110 40.18 -160.71 REMARK 500 THR B 141 -104.12 -119.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 MES A 302 REMARK 615 MES B 302 REMARK 615 GSH A 301 REMARK 615 GSH B 301 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GSH A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GSH B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6LLC RELATED DB: PDB REMARK 900 NQO1 DBREF 6LLX A 0 209 UNP P09211 GSTP1_HUMAN 1 210 DBREF 6LLX B 0 209 UNP P09211 GSTP1_HUMAN 1 210 SEQADV 6LLX SER A -5 UNP P09211 EXPRESSION TAG SEQADV 6LLX HIS A -4 UNP P09211 EXPRESSION TAG SEQADV 6LLX MET A -3 UNP P09211 EXPRESSION TAG SEQADV 6LLX ALA A -2 UNP P09211 EXPRESSION TAG SEQADV 6LLX SER A -1 UNP P09211 EXPRESSION TAG SEQADV 6LLX SER B -5 UNP P09211 EXPRESSION TAG SEQADV 6LLX HIS B -4 UNP P09211 EXPRESSION TAG SEQADV 6LLX MET B -3 UNP P09211 EXPRESSION TAG SEQADV 6LLX ALA B -2 UNP P09211 EXPRESSION TAG SEQADV 6LLX SER B -1 UNP P09211 EXPRESSION TAG SEQRES 1 A 215 SER HIS MET ALA SER MET PRO PRO TYR THR VAL VAL TYR SEQRES 2 A 215 PHE PRO VAL ARG GLY ARG CYS ALA ALA LEU ARG MET LEU SEQRES 3 A 215 LEU ALA ASP GLN GLY GLN SER TRP LYS GLU GLU VAL VAL SEQRES 4 A 215 THR VAL GLU THR TRP GLN GLU GLY SER LEU LYS ALA SER SEQRES 5 A 215 CYS LEU TYR GLY GLN LEU PRO LYS PHE GLN ASP GLY ASP SEQRES 6 A 215 LEU THR LEU TYR GLN SER ASN THR ILE LEU ARG HIS LEU SEQRES 7 A 215 GLY ARG THR LEU GLY LEU TYR GLY LYS ASP GLN GLN GLU SEQRES 8 A 215 ALA ALA LEU VAL ASP MET VAL ASN ASP GLY VAL GLU ASP SEQRES 9 A 215 LEU ARG CYS LYS TYR ILE SER LEU ILE TYR THR ASN TYR SEQRES 10 A 215 GLU ALA GLY LYS ASP ASP TYR VAL LYS ALA LEU PRO GLY SEQRES 11 A 215 GLN LEU LYS PRO PHE GLU THR LEU LEU SER GLN ASN GLN SEQRES 12 A 215 GLY GLY LYS THR PHE ILE VAL GLY ASP GLN ILE SER PHE SEQRES 13 A 215 ALA ASP TYR ASN LEU LEU ASP LEU LEU LEU ILE HIS GLU SEQRES 14 A 215 VAL LEU ALA PRO GLY CYS LEU ASP ALA PHE PRO LEU LEU SEQRES 15 A 215 SER ALA TYR VAL GLY ARG LEU SER ALA ARG PRO LYS LEU SEQRES 16 A 215 LYS ALA PHE LEU ALA SER PRO GLU TYR VAL ASN LEU PRO SEQRES 17 A 215 ILE ASN GLY ASN GLY LYS GLN SEQRES 1 B 215 SER HIS MET ALA SER MET PRO PRO TYR THR VAL VAL TYR SEQRES 2 B 215 PHE PRO VAL ARG GLY ARG CYS ALA ALA LEU ARG MET LEU SEQRES 3 B 215 LEU ALA ASP GLN GLY GLN SER TRP LYS GLU GLU VAL VAL SEQRES 4 B 215 THR VAL GLU THR TRP GLN GLU GLY SER LEU LYS ALA SER SEQRES 5 B 215 CYS LEU TYR GLY GLN LEU PRO LYS PHE GLN ASP GLY ASP SEQRES 6 B 215 LEU THR LEU TYR GLN SER ASN THR ILE LEU ARG HIS LEU SEQRES 7 B 215 GLY ARG THR LEU GLY LEU TYR GLY LYS ASP GLN GLN GLU SEQRES 8 B 215 ALA ALA LEU VAL ASP MET VAL ASN ASP GLY VAL GLU ASP SEQRES 9 B 215 LEU ARG CYS LYS TYR ILE SER LEU ILE TYR THR ASN TYR SEQRES 10 B 215 GLU ALA GLY LYS ASP ASP TYR VAL LYS ALA LEU PRO GLY SEQRES 11 B 215 GLN LEU LYS PRO PHE GLU THR LEU LEU SER GLN ASN GLN SEQRES 12 B 215 GLY GLY LYS THR PHE ILE VAL GLY ASP GLN ILE SER PHE SEQRES 13 B 215 ALA ASP TYR ASN LEU LEU ASP LEU LEU LEU ILE HIS GLU SEQRES 14 B 215 VAL LEU ALA PRO GLY CYS LEU ASP ALA PHE PRO LEU LEU SEQRES 15 B 215 SER ALA TYR VAL GLY ARG LEU SER ALA ARG PRO LYS LEU SEQRES 16 B 215 LYS ALA PHE LEU ALA SER PRO GLU TYR VAL ASN LEU PRO SEQRES 17 B 215 ILE ASN GLY ASN GLY LYS GLN HET GSH A 301 21 HET MES A 302 12 HET GSH B 301 21 HET MES B 302 12 HETNAM GSH GLUTATHIONE HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID FORMUL 3 GSH 2(C10 H17 N3 O6 S) FORMUL 4 MES 2(C6 H13 N O4 S) FORMUL 7 HOH *426(H2 O) HELIX 1 AA1 ARG A 11 ARG A 13 5 3 HELIX 2 AA2 CYS A 14 GLN A 24 1 11 HELIX 3 AA3 THR A 34 GLY A 41 1 8 HELIX 4 AA4 GLY A 41 CYS A 47 1 7 HELIX 5 AA5 GLN A 64 GLY A 77 1 14 HELIX 6 AA6 ASP A 82 ASN A 110 1 29 HELIX 7 AA7 ASN A 110 GLN A 135 1 26 HELIX 8 AA8 ASN A 136 LYS A 140 5 5 HELIX 9 AA9 SER A 149 ALA A 166 1 18 HELIX 10 AB1 PHE A 173 ALA A 185 1 13 HELIX 11 AB2 ARG A 186 ALA A 194 1 9 HELIX 12 AB3 SER A 195 ASN A 200 1 6 HELIX 13 AB4 ARG B 11 ARG B 13 5 3 HELIX 14 AB5 CYS B 14 GLN B 24 1 11 HELIX 15 AB6 THR B 34 GLY B 41 1 8 HELIX 16 AB7 GLY B 41 CYS B 47 1 7 HELIX 17 AB8 GLN B 64 GLY B 77 1 14 HELIX 18 AB9 ASP B 82 ASN B 110 1 29 HELIX 19 AC1 ASN B 110 GLN B 135 1 26 HELIX 20 AC2 ASN B 136 LYS B 140 5 5 HELIX 21 AC3 SER B 149 ALA B 166 1 18 HELIX 22 AC4 PHE B 173 ALA B 185 1 13 HELIX 23 AC5 ARG B 186 SER B 195 1 10 HELIX 24 AC6 SER B 195 ASN B 200 1 6 SHEET 1 AA1 4 TRP A 28 VAL A 32 0 SHEET 2 AA1 4 TYR A 3 TYR A 7 1 N VAL A 5 O GLU A 31 SHEET 3 AA1 4 LYS A 54 ASP A 57 -1 O LYS A 54 N VAL A 6 SHEET 4 AA1 4 LEU A 60 TYR A 63 -1 O LEU A 62 N PHE A 55 SHEET 1 AA2 4 TRP B 28 VAL B 32 0 SHEET 2 AA2 4 TYR B 3 TYR B 7 1 N VAL B 5 O GLU B 31 SHEET 3 AA2 4 LYS B 54 ASP B 57 -1 O LYS B 54 N VAL B 6 SHEET 4 AA2 4 LEU B 60 TYR B 63 -1 O LEU B 62 N PHE B 55 CISPEP 1 LEU A 52 PRO A 53 0 7.03 CISPEP 2 LEU B 52 PRO B 53 0 6.67 SITE 1 AC1 2 TYR A 7 PHE A 8 SITE 1 AC2 2 TYR B 7 PHE B 8 CRYST1 69.655 82.179 89.324 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014356 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012169 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011195 0.00000